Objective To compare the efficacy and side effects of mirtazapine and amitriptyline in the treatment of depressive and anxiety patients. 目的探讨米氮平和阿咪替林在治疗抑郁焦虑方面的疗效与副反应。
Mirtazapine responded more quickly and showed significant improvement of anxiety symptoms at the beginning of the treatment. 目的:比较米氮平与帕罗西汀治疗伴有焦虑症状抑郁症的疗效。
Objective To explore the efficacy and side effects of mirtazapine in the treatment of depression in childhood. 目的探讨米氮平治疗儿童抑郁症患者的疗效及不良反应。
Effect of Mirtazapine on Irritable Bowel Syndrome and Changes of Neuropeptide-Y Level 米氮平联合匹维溴胺治疗肠易激综合征的效果及其对神经肽Y水平的影响
A Comparative Study of Mirtazapine and Fluoxetine in Treatment of Elderly Depressive Patients with Insomnia 米氮平与氟西汀治疗以失眠为主诉的老年抑郁症患者的对照研究
The Study of Mirtazapine in the Treatment of Patients with Post-schizophrenic Depression 米氮平治疗精神分裂症后抑郁的临床研究
The observation on the effect of mirtazapine combined with cognitive therapy in the treatment of post-stroke depression 米氮平联合认知疗法治疗脑卒中后抑郁的疗效观察
Conclusion Mirtazapine is a safe, effective antidepressant with rapid response. 结论米氮平是一种安全、有效的新型抗抑郁药物,起效较快。
A comparative study of mirtazapine and fluoxetine in the treatment of post-stroke depression-anxiety disorder 米氮平与氟西汀治疗脑卒中后抑郁焦虑障碍对照研究
Comparative Study of Mirtazapine and Citalopram in Treatment of Somatoform Disorder 米氮平与西酞普兰治疗躯体形式障碍的对照研究
The Effects of Venlafaxine and Mirtazapine on Sleep in Depressed Patients and the Relation of These Effects and Curative Effect; Steeping is the best cure for waking troubles. 文拉法新和米氮平对抑郁症患者睡眠的影响及其与疗效的关系睡眠是治疗一切醒时烦忧的良药。
Simultaneous Determination of Clozapine, Olanzapine and Mirtazapine in Human Plasma by LC-MS/ MS LC-MS/MS同时测定人血浆中氯氮平、奥氮平和米氮平
Objective To explore efficacy and side effects of mirtazapine. 目的探讨米氮平治疗抑郁症的疗效与安全性。
Mirtazapine's more rapid effect is prominent on all symptoms of depression especailly on anxiety-somatization, retardation and sleep disturbance. 瑞美隆更迅速的起效作用在抑郁症的各个症状均有突出表现,尤其是焦虑-失眠,迟滞和睡眠障碍。
Objective: To evaluate the efficacy and safety of mirtazapine in the treatment of cardiovascular neurosis with depression. 目的:评价米氮平治疗伴抑郁的心血管神经症的临床疗效和安全性。
Methods: 60 patients with cardiovascular neurosis with depression were randomly treated with mirtazapine or fluoxetine. 方法:将60例伴抑郁的心血管神经官能症患者随机分为米氮平组和氟西汀组,进行为期42天的治疗观察。
Conclusion: mirtazapine had good effectiveness in the depressed patients with anxiety symptoms. 结论:米氮平对伴有焦虑症状的抑郁症有良好的疗效。
The incidence condition of adverse reaction in the mirtazapine treatment group and amitriptyline treatment group during curative period was recorded. 记录治疗期间米氮平治疗组和阿米替林治疗组不良反应发生情况。
Comparative Study of Mirtazapine and Fluoxetine in the Treatment of Senile Depression 米氮平与氟西丁治疗老年抑郁症患者的对照研究
Conclusion Mirtazapine has diphasic action of anti-depression and-anxiety, its effect of anti-depression is equivalent to imipramine and that of anti-anxiety superior to imipramine, and has significant efficacy, higher safety and better compliance in depression associated with anxious symptoms. 结论米氮平具有抗抑郁抗焦虑双重作用,抗抑郁作用与丙米嗪相当,抗焦虑作用优于丙米嗪,治疗抑郁症伴焦虑症状疗效显著,安全性高、依从性好。
Observation of clinical therapeutic effect of mirtazapine on chronic cerebral circulation insufficiency complicated by anxious and depressive neurosis 米氮平治疗慢性脑供血不足并发焦虑、抑郁性神经症疗效观察
Conclusion: Mirtazapine has better efficacy and less adverse effects in the maintenance treatment of depression. 结论:抑郁症患者对米氮平依从性高主要是因疗效好,不良反应轻。
Clinical Evaluation of Mirtazapine and Clomipramine for the Treatment of Depressive Disorder Associated with Anxiety 米氮平与氯丙米嗪治疗抑郁症伴有焦虑的临床评价
Comparison of Therapeutic Effects between Mirtazapine and Alprazolam on Chronic Insomnia 米氮平与阿普唑仑治疗慢性失眠症的临床疗效比较
Mirtazapine and Fluoxetine in Treating Depression: Cost-minimization Analysis 米氮平与氟西汀治疗抑郁症的最小成本分析
Comparison of Mirtazapine United With Wuling Capsule and Mirtazapine Alone for Depression and Anxiety Comorbidity 米氮平联合乌灵胶囊及单一米氮平治疗抑郁和焦虑障碍共病的疗效对照
Conclusion Mirtazapine is of good efficacy, rapid action, and less side effects in treatment of depression. 结论米氮平治疗抑郁症疗效好、起效快、副反应较低。
Objective: To synthesize antidepressant mirtazapine. 目的:合成抗抑郁药米氮平。
Objective: To investigate the clinical efficacy and compliance with a new antidepressant mirtazapine to treat depressive patients. 目的:探讨新型抗抑郁药物米氮平的临床疗效及治疗依从性。
Methods: 67 cases according to the diagnostic standard both for depression and anxiety disorder were administered randomly mirtazapine united with Wuling capsule ( briefly group A) or mirtazapine alone ( briefly group B). 方法:67例同时符合抑郁症与焦虑障碍诊断标准的门诊患者,分别随机给予口服米氮平联合乌灵胶囊(简称A组)和单一口服米氮平(简称B组)。